Elicio Therapeutics, Inc. Common Stock ELTX
HEALTHCARE · BIOTECHNOLOGYi
Market datapartial · fetched 2026-11-12T03:09:57.773Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-05-21
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T22:14:52.778395762Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T03:09:56.375456+00:00
Elicio Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | 2.70 | 132.3% | 19.5% | |||
| 55Δ | 3.66 | 138.9% | 15.6% | |||
| 60Δ | 4.62 | 145.5% | 11.7% | |||
| 65Δ | 5.57 | 152.0% | 7.8% | |||
| 70Δ | 6.53 | 158.6% | 3.9% | |||
| 75Δ | 7.49 | 165.2% | 0.0% | |||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.70
- IV
- 132.3%
- B/E move
- 19.5%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.66
- IV
- 138.9%
- B/E move
- 15.6%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.62
- IV
- 145.5%
- B/E move
- 11.7%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.57
- IV
- 152.0%
- B/E move
- 7.8%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.53
- IV
- 158.6%
- B/E move
- 3.9%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.49
- IV
- 165.2%
- B/E move
- 0.0%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
ELVN
Enliven Therapeutics Inc. (Ticker: ELVN) is an innovative biotechnology company focused on transforming cancer therapies and addressing critical healthcare challenges through its…
More →ENGN
enGene Holdings Inc., through its subsidiary enGene, Inc., is a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to…
More →ENTA
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is…
More →ENTX
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies for unmet medical…
More →ERAS
Erasca Inc. is a pioneering biopharmaceutical firm specializing in the development of targeted therapies for genetically defined cancers, aiming to meet significant unmet needs in…
More →EVMN
Evommune, Inc. is an innovative biotechnology company focused on developing cutting-edge therapeutics for immunological disorders, targeting significant unmet medical needs in…
More →